Articles

Antioxidants and other polyphenols present in coffee confer healthy benefits to the body, which may include lowering insulin resistance, inflammation and biomarkers of liver function.

The treatment of choice for obese T2D patients is weight loss.

Earlier initiation of diabetes medications can lead to reduced heart disease risk in type 2 patients.

Management of non-glycemic cardiovascular disease risk factors may have increasing benefits in an aging type 1 diabetes patient population with long-term hyperglycemia.

Guest Post by David Kliff, Diabetic Investor. New diabetes technology sounds promising, but will products like One Drop really change patients' -- or payers' -- behavior?

Dr. Stuart Weiss discusses preferred diabetes medications and new diabetes technologies, such as CGMs.

Increase in BMI and A1c leads to coronary issues.

Only 6% of PCP’s were able to identify 11 prediabetes risk factors (there are actually 13) that would prompt them to screen patients under the ADA guidelines according to a new study. Are you any better?

Long-term uncontrolled glycemic levels primary cause of complication.

Beta-blocker use in patients with T2DM and established CV risk factors associated with increased risk of CV events and severe hypoglycemia, according to recent study.